A History of Innovation Mission & Core Values Notable Facts & Statistics Leadership Our Directory Accreditation Giving Careers at MCPHS University Important Notices Contact

Our Directory

Bio

Matthew Silva, PharmD, RPh, BCPS
Professor of Pharmacy Practice

Department/Office
Pharmacy Practice - 19 Foster Street, DBEN 503
School of Pharmacy
Contact
matt.silva@mcphs.edu
(P)508.373.5669


Schools
School of Pharmacy - Worcester/Manchester

Programs
Pharmacy (PharmD)

Education
PharmD, Northeastern University

Professional Licensure/Certification
Basic Life Support
Registered Pharmacist, Commonwealth of Massachusetts
APhA Pharmacist Immunization Certification
Board Certified Pharmacotherapy Specialist


Areas of Teaching
Pharmacy Practice in Family Medicine
Primary Care/Ambulatory Care
Chronic Disease Management
Outpatient Cardiology
Evidence based medicine
Biostatistics and meta-analysis


Scholarly Interests
Pharmacy practice in Family Medicine
Primary Care
Prevention and treatment of lifestyle diseases
Diabetes prevention and management
Outcomes research and pharmacoeconomics
EBM, biostatistics and meta-analysis
Technology in the classroom


Peer-Reviewed Articles & Book Chapters
Han E, Silva MA, Baxter J.  Drug Abuse, Prescription. In: Domino FJ, ed. The 5-Minute Clinical Consult 2015. 23rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2015

Key S, Valdman O, Silva MA. Diptheria. In: Domino FJ, ed. The 5-Minute Clinical Consult 2015. 23rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2015

Silva MA, Hernandez PI.  Hypoglycemia, non-diabetic. The 5-Minute Clinical Consult 2015. 23rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2015

Silva MA, Hernandez PI.  Stevens-Johnson Syndrome. The 5-Minute Clinical Consult 2015. 23rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2015

Silva M, van Valkenhoef G. The Future of Network Meta-Analysis: Toward Accessibility and Integration. In: Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison 2015, 1st ed. Hauppauge, NY: Nova Science Publishers 2015

Malloy R, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013;35:1490-1500.

Assiri A, Al-Majzoub O, Donovan JL, Kanaan AO, Silva MA. Mixed treatment comparison meta analysis of aspirin, warfarin and new anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.  Clin Ther. 2013;35:967-84.

Rollins B, Lee D, Silva MA. Insulin dosage preparation and administration: prefilled pens versus syringes.  J Pharm Pract Res 2013;43:198-201

Silva MA, Chuong M, Kerr S. Cabrera A. Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice and Research. 2013, 43(1): 37-40.

Sitole M, Silva MA, Spooner L, Comee MK, Malloy M. Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of phase II and III trials.  Clin Ther 2013 (35)2:190-7

Silva MA, Cashman SB, Kunte P, Candib LM. Improving population health through Iintegration of primary care and public health: Providing access to physical activity for community health center patients. Am J Public Health. 2012 Nov;102(11):e56-61

Cashman S, Candib L, Silva MA. Partnering for health: Collaborative leadership between a community health center and the YMCA. J Public Health Manag Pract 2012;18(3)279-287

Pervanas HC, Silva MA, Willett KC, Cooper MR, Durand C, Belliveau PP, Abel C.  Health perception changes of state employees following a health screening event. J Pharm Technol 2012;28:47-50

Durand C, Abel C, Silva MA, Desilets A. An interactive pharmacy elective course in cultural competence.  Currents in Pharmacy Teaching and Learning 2012;4(2)102-108

Donovan JL, Kanaan AO, Silva MA, Horton ER, Abel C, Belliveau PP. Assessment of CAPE outcomes in a capstone course of an accelerated pharmacy program. Currents in Pharmacy Teaching and Learning  2011;3(4)299-306

Carey KM, Cross JE, Silva MA, Stefan MS, Rothberg MB.  Pharmacy student impact on inappropriate prescribing of acid suppressant therapy. Am J Pharm Educ 2011;75(9):175

Shaughnessey P, Islas-Ohlmayer M, Murphy J, Hougham M, MacPherson J, Winkler K, Silva MA, Steinberg M, Matous J, Selvey S, Maris M, McSweeney P. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide.  Biol Blood Marrow Transplant. 2011;17(5):729-36.

Steinberg M, Silva MA. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.  Clin Ther 2010;32(5):821-43.

Serebruany V, Rao S, Silva MA, Donovan JL, Kanaan AO, Makarov L, Gota S, Atar D. Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: Assessment by different bleeding classifications.  European Heart Journal 2010;2:227-235

Jarvis CI, Seed SM, Silva MA, Sullivan KM. Educational Campaign for Proper Medication Disposal. J Am Pharm Assoc. 2009;49:65-68.

Larochelle PA, Giang DK, Silva MA, Kcomt M, Malloy MJ, Kay S, Ku MT. Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity. AJPE 2009;73:1-9.

Candib LM, Silva M, Cashman SB, Ellstrom D, Mallett K. Creating Open Access to Exercise for Low-income Patients Through a Community Collaboration for Quality Improvement: If You Build It, They Will Come. Journal of Ambulatory Care Management 2008;2:142-150.

Silva MA, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi PJ. Meta-analysis of drug induced adverse events associated with intensive statin therapy. Clin Ther. 2007;29:253-260.

Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: A meta-analysis. Clin Ther. 2006;28:26-35.

Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manage. 2006; 2(1):39948.

Silva MA, Gandhi PG. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? J Clin Pharm Ther. 2005

Chan KY, Boucher ES, Gandhi PJ, Silva MA. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. Am J Health Syst Pharm. 2004. 61;1676-81.

Silva MA. PDAs in clinical practice: Applications and trends. Hospital Pharmacy Europe (HPE) 2003. 11;75-77

Silva MA, Maas B. Using personal digital assistants to document pharmacist cognitive services and estimate potential reimbursement. Am J Health-Syst Pharm 2003. 60;911-915


Editorials
Silva MA, Cashman S, Candib L. Silva et. al. respond to a more holistic approach needed to physical activity access by all. Am J Public Health 2013;(103)e3-4, doi: 10.2105/AJPH.2013.301216

Silva MA, Spooner LM. 2009 H1N1 Pandemic Influenza: Let’s Get Involved. Journal of Pharmacy Practice Research 2009; 39:4 (259-61)

Silva MA. Community collaboration for the prevention and treatment of diabetes in Worcester. Worcester Medicine, 2009. Jan-Feb. 18-21.


Current Professional Memberships, Service & Leadership
American Association of Colleges of Pharmacy (AACP)
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacy (ASHP)


Personal Interests
Drums
Music
Computing and medical informatics